These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 28663326)

  • 41. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.
    Menéndez A; Gómez J; Caminal-Montero L; Díaz-López JB; Cabezas-Rodríguez I; Mozo L
    ScientificWorldJournal; 2013; 2013():832789. PubMed ID: 24294139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presymptomatic autoantibodies in Sjögren's syndrome: what significance do they hold for the clinic?
    Henriksson G
    Expert Rev Clin Immunol; 2014 Jul; 10(7):815-7. PubMed ID: 24867307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases.
    Infantino M; Meacci F; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Ott A; Meyer W; Atzeni F; Sarzi-Puttini P; Manfredi M; Bizzaro N
    Arthritis Res Ther; 2015 Dec; 17():365. PubMed ID: 26673754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus.
    Kvarnström M; Dzikaite-Ottosson V; Ottosson L; Gustafsson JT; Gunnarsson I; Svenungsson E; Wahren-Herlenius M
    Lupus; 2013 Apr; 22(5):477-85. PubMed ID: 23554036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.
    Aqrawi LA; Skarstein K; Øijordsbakken G; Brokstad KA
    Clin Exp Immunol; 2013 May; 172(2):228-37. PubMed ID: 23574319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
    Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
    Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding.
    Terzoglou AG; Routsias JG; Moutsopoulos HM; Tzioufas AG
    Clin Exp Immunol; 2006 Oct; 146(1):60-5. PubMed ID: 16968399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
    Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
    Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.
    Chan EKL
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):178-193. PubMed ID: 35040083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dry eyes: autoimmunity and relationship to other systemic disease.
    Maddison PJ
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 4)():458-61. PubMed ID: 3898478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent pregnancy loss and autoantibody profile in autoimmune diseases.
    Mavragani CP; Ioannidis JP; Tzioufas AG; Hantoumi IE; Moutsopoulos HM
    Rheumatology (Oxford); 1999 Dec; 38(12):1228-33. PubMed ID: 10587550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome.
    Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; Deprez J; Van den Bosch F; Elewaut D; Peene I
    Clin Exp Rheumatol; 2022 Dec; 40(12):2310-2317. PubMed ID: 36200940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies.
    Deshmukh US; Lewis JE; Gaskin F; Kannapell CC; Waters ST; Lou YH; Tung KS; Fu SM
    J Exp Med; 1999 Feb; 189(3):531-40. PubMed ID: 9927515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current state of technologies and recognition of anti-SSA/Ro antibodies in China: A multi-center study.
    Chen YL; Hu CJ; Peng LY; Wang CH; Zhao Y; Zhang W; Liu DZ;
    J Clin Lab Anal; 2021 Dec; 35(12):e24045. PubMed ID: 34674312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IgV peptide mapping of native Ro60 autoantibody proteomes in primary Sjögren's syndrome reveals molecular markers of Ro/La diversification.
    Wang JJ; Al Kindi MA; Colella AD; Dykes L; Jackson MW; Chataway TK; Reed JH; Gordon TP
    Clin Immunol; 2016 Dec; 173():57-63. PubMed ID: 27609500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.
    Zimmermann C; Smolen JS; Graninger W; Petera P; Fabini G; Hassfeld W; Höfler E; Steiner G
    J Rheumatol; 1996 Nov; 23(11):1897-903. PubMed ID: 8923363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sjögren's syndrome.
    Duda S; Witte T; Stangel M; Adams J; Schmidt RE; Baerlecken NT
    Immunol Res; 2017 Dec; 65(6):1099-1102. PubMed ID: 29138979
    [No Abstract]   [Full Text] [Related]  

  • 59. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
    Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
    J Immunol; 2006 May; 176(10):6277-85. PubMed ID: 16670339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.